FDA NDC Directory · JSON-LD · Markdown

Regadenoson

NDC 76329-3321 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerInternational Medication Systems, Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA214252
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsREGADENOSON ANHYDROUS (.08 mg/mL)
Marketing started20230420
Package count1

External sources

Source: openFDA. Public-domain (CC0).